MLAB — MESA LABORATORIES INC /CO/

Nasdaq · Unknown · Unknown · CIK 724004 ·
Last close
$104.08
Market Cap
$575.03M
52W High
$113.99
52W Low
$76.77
ADV30
205,934
Next earnings
2026-08-05
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026
Dec 2025 65,126,000 41,795,000 7,975,000 3,630,000 434,849,000 28,975,000 248,158,000
Sep 2025 60,737,000 37,331,000 4,724,000 2,476,000 430,351,000 20,422,000 251,883,000
Jun 2025 59,543,000 36,939,000 3,064,000 4,742,000 435,743,000 21,279,000 263,247,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$41,534,000
Investing CF
$-3,840,000
Financing CF
$-42,288,000
CapEx
$-3,840,000
Dividends Paid
$-3,509,000
Buybacks
EPS Diluted TTM
$1.20
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-185,747,000
Inventory
$26,373,000
Receivables
$44,099,000
ST Investments
EBIT TTM
$22,706,000
Pretax Income TTM
$12,014,000
Interest Exp TTM
$10,692,000
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$249,130,000
EBITDA
$41,782,000
Free Cash Flow
$31,884,876
Enterprise Value
$723,028,736
Total Cash
$28,572,000
Total Debt
$168,831,008
Shares Out
5,524,931
Trailing EPS
$1.21
Book Value
$33.79
ROE
3.9%
ROA
2.7%
Div Yield
0.61%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Mar 2026 249,130,000 18,511,000 6,712,000 427,747,000 241,502,000 42,831,000
Mar 2025 240,978,000 16,336,000 -1,974,000 433,348,000 273,518,000 46,808,000
Mar 2024 216,187,000 2,458,000 -254,246,000 446,796,000 301,403,000 44,133,000
Mar 2023 219,080,000 3,320,000 930,000 661,832,000 268,352,000 27,983,000
Mar 2022

TTM Snapshot

Revenues TTM
$62,840,000
NetIncome TTM
$-1,676,000
OpCashFlow TTM
$0
Assets (Latest)
$433,348,000
Forward EPS
$12.27

Peers — same industry

TickerNameMarket CapLastDaily %
THSGF THESIS GOLD INC. $574.63M $2.06
NML Neuberger Energy Infrastructure & Income Fund Inc. $569.42M $10.05
BATRA Atlanta Braves Holdings, Inc. $567.60M $55.01
MRRDF Meridian Mining UK Societas $582.62M $1.20
AVK ADVENT CONVERTIBLE & INCOME FUND $565.99M $12.82

News headlines (Yahoo Finance, 1h cache)

3 Stocks Estimated To Be Trading 16.4% To 42% Below Intrinsic Value
2026-06-04 17:38 · Yahoo
Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today
2026-05-27 19:56 · Yahoo
Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results
2026-05-27 12:00 · Yahoo
Undervalued Small Caps With Insider Buying Across Regions
2026-05-22 11:39 · Yahoo
Undervalued Small Caps With Insider Buying Across Regions To Consider
2026-04-20 11:39 · Yahoo
MESA LABS DECLARES QUARTERLY DIVIDEND
2026-04-02 22:00 · Yahoo
Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO
2026-03-09 20:30 · Yahoo
Here’s Why Conestoga Capital Advisors Sold Mesa Laboratories (MLAB)
2026-02-20 12:02 · Yahoo
As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense
2026-02-18 14:00 · Yahoo
Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?
2026-02-05 10:17 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.